Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.

CONTEXT Methadone hydrochloride treatment is the most common pharmacological intervention for opioid dependence, and recent interest has focused on expanding methadone treatment availability beyond traditional specially licensed clinics. However, despite recommendations regarding effective dosing of methadone, controlled clinical trials of higher-dose methadone have not been conducted. OBJECTIVE To compare the relative clinical efficacy of moderate- vs high-dose methadone in the treatment of opioid dependence. DESIGN A 40-week randomized, double-blind clinical trial starting in June 1992 and ending in October 1995. SETTING Outpatient substance abuse treatment research clinic at the Johns Hopkins University Bayview Campus, Baltimore, Md. PARTICIPANTS One hundred ninety-two eligible clinic patients. INTERVENTION Daily oral methadone hydrochloride in the dose range of 40 to 50 mg (n = 97) or 80 to 100 mg (n = 95), with concurrent substance abuse counseling. MAIN OUTCOME MEASURES Opioid-positive urinalysis results and retention in treatment. RESULTS By intent-to-treat analysis through week 30 patients in the high-dose group had significantly lower rates of opioid-positive urine samples compared with patients in the moderate-dose group (53.0% [95% confidence interval [CI], 46.9%-59.2%] vs 61.9% [95% CI, 55.9%-68.0%]; P = .047. These differences persisted during withdrawal from methadone. Through day 210 no significant difference was evident between dose groups in treatment retention (high-dose group mean retention, 159 days; moderate-dose group mean retention, 157 days). Nineteen (33%) of 57 patients in the high-dose group and 11 (20%) of 54 patients in the moderate-dose group completed detoxification. CONCLUSIONS Both moderate- and high-dose methadone treatment resulted in decreased illicit opioid use during methadone maintenance and detoxification. The high-dose group had significantly greater decreases in illicit opioid use.

[1]  W. H. Hall,et al.  Effective medical treatment of opiate addiction , 1998 .

[2]  Judith D. Singer,et al.  Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models , 1998 .

[3]  M. Stitzer,et al.  Useful predictors of outcome in methadone-treated patients : Results from a controlled clinical trial with three doses of methadone , 1998 .

[4]  D. Ziedonis,et al.  Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. , 1997, Archives of general psychiatry.

[5]  W. Ling,et al.  A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. , 1996, Archives of general psychiatry.

[6]  P. Diggle.  Analysis of Longitudinal Data , 1995 .

[7]  S D Imber,et al.  Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. , 1993, Archives of general psychiatry.

[8]  M. Stitzer,et al.  Methadone dose and treatment outcome. , 1993, Drug and alcohol dependence.

[9]  M. Stitzer,et al.  Dose-Response Effects of Methadone in the Treatment of Opioid Dependence , 1993, Annals of Internal Medicine.

[10]  D. Ziedonis,et al.  Buprenorphine versus Methadone Maintenance for Opioid Dependence , 1993, The Journal of nervous and mental disease.

[11]  J. Jaffe,et al.  A controlled trial of buprenorphine treatment for opioid dependence. , 1992, JAMA.

[12]  T. Farley,et al.  Predictors of outcome in methadone programs: effect of HIV counseling and testing , 1992, Connecticut medicine.

[13]  M. Stitzer,et al.  Predictors of opiate drug abuse during a 90-day methadone detoxification. , 1991, The American journal of drug and alcohol abuse.

[14]  Alan Ross,et al.  The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome , 1991 .

[15]  C. Klett,et al.  Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study. , 1976, Archives of general psychiatry.

[16]  V. Dole,et al.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. , 1965, JAMA.

[17]  M. Stitzer,et al.  Methadone treatment for opioid dependence , 1999 .

[18]  Jan de Leeuw,et al.  Introducing Multilevel Modeling , 1998 .

[19]  R. Rettig,et al.  Federal regulation of methadone treatment , 1995 .

[20]  T. Farley,et al.  Predictors of outcome in methadone programs: effect of HIV counseling and testing. , 1992, AIDS.

[21]  Alan Ross,et al.  The Effectiveness of Methadone Maintenance Treatment , 1991, Springer New York.

[22]  A. Goldstein,et al.  Proceedings: Efficacy and side effects of three widely different methadone doses. , 1973, Proceedings. National Conference on Methadone Treatment.